Abstract
We report the successful treatment of refractory cancer pain by bilateral intrathecal neurolysis using phenol–glycerol. A 60-year-old man had recurrent sigmoid cancer and metastases to the lumbar (L4–5) and sacral bones. He complained of refractory pain in the lower back and lower extremities despite high-dose opioid treatment based on the WHO ladder. On admission to our hospital, he received continuous intravenous infusion of morphine (7,000 mg/day) with ketamine (300 mg/day) and lidocaine (700 mg/day). Intravenous midazolam was required to treat extreme anxiety. Because of inadequate pain relief and severe drowsiness, intrathecal phenol–glycerol neurolytic block was performed twice at the L2/3 intervertebral space. His analgesia was greatly improved and high-dose intravenous opioid was retitrated and ceased. He remained comfortable and lucid at home for 2 months, until 2 days before his death at hospital. Intrathecal neurolytic block may be appropriate for some patients suffering from refractory pain that is resistant to conventional opioid analgesic treatment.
Similar content being viewed by others
References
World Health Organization. Cancer Pain Relief. Albany: WHO Publications Center; 1986.
Zech DF, Grond S, Lynch J, Hertel D, Lehmann KA. Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study. Pain. 1995;63:65–76.
Miguel R. Interventional treatment of cancer pain: the fourth step in the World Health Organization analgesic ladder? Cancer Control. 2000;7:149–56.
Sloan PA. The evolving role of interventional pain management in oncology. J Support Oncol. 2004;2:491–500.
Jackson TP, Gaeta R. Neurolytic blocks revisited. Curr Pain Headache Rep. 2008;12:7–13.
Tei Y, Morita T, Nakaho T, Takigawa C, Higuchi A, Suga A, Tajima T, Ikenaga M, Higuchi H, Shimoyama N, Fujimoto M. Treatment efficacy of neural blockade in specialized palliative care services in Japan: a multicenter audit survey. J Pain Symptom Manage. 2008;36:461–7.
Chambers WA. Nerve blocks in palliative care. Br J Anaesth. 2008;101:95–100.
Tay W, Ho KY. The role of interventional therapies in cancer pain management. Ann Acad Med Singapore. 2009;38:989–97.
Christo PJ, Mazloomdoost D. Interventional pain treatments for cancer pain. Ann NY Acad Sci. 2008;1138:299–328.
Gerbershagen HU. Neurolysis. Subarachnoid neurolytic blockade. Acta Anaesthesiol Belg. 1981;32:45–57.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Watanabe, A., Yamakage, M. Intrathecal neurolytic block in a patient with refractory cancer pain. J Anesth 25, 603–605 (2011). https://doi.org/10.1007/s00540-011-1141-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00540-011-1141-4